Glycine supplement for fatty liver disease
Part of Digestive system clinical trials.
This study tests whether a simple dietary supplement (glycine, an amino acid) can improve fatty liver disease. Participants with mild-to-moderate fatty liver will take glycine daily for several months to see if it reduces liver fat and improves health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 70 years old
- You have fatty liver disease (confirmed by MRI) and a BMI between 25 and 50
- You do not have other liver diseases like hepatitis or cirrhosis
- You do not drink heavily (more than 1-2 drinks per day)
- You are not taking certain weight-loss or diabetes medications (like Ozempic)
- You are able to have an MRI (no metal implants, no claustrophobia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether aspirin can help people with MASLD, a type of fatty liver disease linked to conditions like diabetes and obesity. It aims to see if aspirin can improve liver health without causing harm.
This trial tests whether a form of folic acid (5-methyltetrahydrofolate) can help people with fatty liver disease. It may improve liver health by supporting fat and sugar processing.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This study tests whether a special supplement (made from cacao, nopal, and crickets) can help improve fatty liver disease in people with excess body fat. Fatty liver disease happens when fat builds up in the liver, and this trial investigates whether these natural ingredients can reduce that buildup.
This study compares different diet plans to see which works best to reduce fat in the liver of children and teens with MASLD (a type of fatty liver disease). If your child drinks sugary beverages often and has certain health risks like being overweight or having high cholesterol, this trial may help find a healthy eating plan that works.
This trial tests a new medication called ACT500 for people with fatty liver disease (MASLD). The goal is to see if it is safe and how the body processes it. You may be able to join if you have at least 10% liver fat, some liver scarring or damage, and certain metabolic risk factors like being overweight or having prediabetes.
Hear when a new Metabolic Dysfunction-associated Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.